Table 4

Insulin use in OAD plus insulin group, by insulin treatment duration
Insulin treatment duration (yrs) n (%)a Prandial, n (%)b Basal, n (%)b Basal-bolus, n (%)b Premixes, n (%)b Others, n (%)b
<1 21,145 1987 3376 1623 13,825 334
(26.33) (9.40) (15.97) (7.68) (65.37) (1.58)
≥1-5 27,617 2171 4992 1711 18,334 409
(34.39) (7.86) (18.08) (6.20) (66.38) (1.48)
≥5-10 18,504 1198 3148 1561 12,280 317
(23.04) (6.47) (17.01) (8.44) (66.37) (1.71)
≥10 13,042 (16.24) 834 (6.39) 2,223 (17.04) 1471 (11.28) 8204 (62.91) 310 (2.38)
Totalc 80,308 6190 13,739 6366 52,643 1370
P valued <0.0001 NS NS NS NS

aPercentage of patients among the full population; bPercentage of patients among the patients with particular insulin treatment duration; cData on diabetes duration were missing for 665 patients using insulin therapy; dChi-square test was used to compare the percentage of patients in different insulin regimens by insulin treatment duration.

NS = not significant.

Ji et al.

Ji et al. BMC Public Health 2013 13:602   doi:10.1186/1471-2458-13-602

Open Data